- call +1-201-465-4211
- email sales@mrinsights.biz
According to this latest study, the 2021 growth of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) will have significant change from previous year. By the most conservative estimates of global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Live Vaccine
Inactivated Vaccine
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Government Tender
Marketing
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
CNADC
Boehringer-Ingelheim
MSD Animal Health
Sinopharm
Ceva
Chengdu Tianbang Biological Products Co., Ltd.
Tianjin Ruipu Biological Technology Co., Ltd.
Qilu Animal Health
Guangdong Wens Dahuanong Biotechnology Co., Ltd.
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Phibro Animal Health
Tiankang
Zoetis
Guangdong Yongshun Biological Pharmaceutical Co Ltd
Plec Bioengineering Co., Ltd.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Consumption 2016-2026
2.1.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Consumption CAGR by Region
2.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Segment by Type
2.2.1 Live Vaccine
2.2.2 Inactivated Vaccine
2.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type
2.3.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2016-2021)
2.3.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue and Market Share by Type (2016-2021)
2.3.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sale Price by Type (2016-2021)
2.4 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Segment by Application
2.4.1 Government Tender
2.4.2 Marketing
2.5 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application
2.5.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sale Market Share by Application (2016-2021)
2.5.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue and Market Share by Application (2016-2021)
2.5.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sale Price by Application (2016-2021)
3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Company
3.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Company
3.1.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Company (2019-2021)
3.1.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Company (2019-2021)
3.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Company
3.2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Company (2019-2021)
3.2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Company (2019-2021)
3.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sale Price by Company
3.4 Global Manufacturers Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Location Distribution
3.4.2 Players Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Region
4.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Region
4.1.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region
4.1.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region
4.2 Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Growth
4.3 APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Growth
4.4 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Growth
4.5 Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Growth
5 Americas
5.1 Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country
5.1.1 Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2016-2021)
5.1.2 Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2016-2021)
5.2 Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type
5.3 Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region
6.1.1 APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2016-2021)
6.1.2 APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region (2016-2021)
6.2 APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type
6.3 APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Country
7.1.1 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2016-2021)
7.1.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2016-2021)
7.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type
7.3 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Country
8.1.1 Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2016-2021)
8.1.2 Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2016-2021)
8.2 Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type
8.3 Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Distributors
10.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Customer
11 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Forecast
11.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Forecast by Region
11.1.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Forecast by Regions (2021-2026)
11.2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Forecast by Type
11.7 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Forecast by Application
12 Key Players Analysis
12.1 CNADC
12.1.1 CNADC Company Information
12.1.2 CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
12.1.3 CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 CNADC Main Business Overview
12.1.5 CNADC Latest Developments
12.2 Boehringer-Ingelheim
12.2.1 Boehringer-Ingelheim Company Information
12.2.2 Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
12.2.3 Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Boehringer-Ingelheim Main Business Overview
12.2.5 Boehringer-Ingelheim Latest Developments
12.3 MSD Animal Health
12.3.1 MSD Animal Health Company Information
12.3.2 MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
12.3.3 MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 MSD Animal Health Main Business Overview
12.3.5 MSD Animal Health Latest Developments
12.4 Sinopharm
12.4.1 Sinopharm Company Information
12.4.2 Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
12.4.3 Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Sinopharm Main Business Overview
12.4.5 Sinopharm Latest Developments
12.5 Ceva
12.5.1 Ceva Company Information
12.5.2 Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
12.5.3 Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Ceva Main Business Overview
12.5.5 Ceva Latest Developments
12.6 Chengdu Tianbang Biological Products Co., Ltd.
12.6.1 Chengdu Tianbang Biological Products Co., Ltd. Company Information
12.6.2 Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
12.6.3 Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Chengdu Tianbang Biological Products Co., Ltd. Main Business Overview
12.6.5 Chengdu Tianbang Biological Products Co., Ltd. Latest Developments
12.7 Tianjin Ruipu Biological Technology Co., Ltd.
12.7.1 Tianjin Ruipu Biological Technology Co., Ltd. Company Information
12.7.2 Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
12.7.3 Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Tianjin Ruipu Biological Technology Co., Ltd. Main Business Overview
12.7.5 Tianjin Ruipu Biological Technology Co., Ltd. Latest Developments
12.8 Qilu Animal Health
12.8.1 Qilu Animal Health Company Information
12.8.2 Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
12.8.3 Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Qilu Animal Health Main Business Overview
12.8.5 Qilu Animal Health Latest Developments
12.9 Guangdong Wens Dahuanong Biotechnology Co., Ltd.
12.9.1 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Company Information
12.9.2 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
12.9.3 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Main Business Overview
12.9.5 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Latest Developments
12.10 CAVAC
12.10.1 CAVAC Company Information
12.10.2 CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
12.10.3 CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 CAVAC Main Business Overview
12.10.5 CAVAC Latest Developments
12.11 Komipharm
12.11.1 Komipharm Company Information
12.11.2 Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
12.11.3 Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Komipharm Main Business Overview
12.11.5 Komipharm Latest Developments
12.12 Agrovet
12.12.1 Agrovet Company Information
12.12.2 Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
12.12.3 Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Agrovet Main Business Overview
12.12.5 Agrovet Latest Developments
12.13 Bioveta
12.13.1 Bioveta Company Information
12.13.2 Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
12.13.3 Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Bioveta Main Business Overview
12.13.5 Bioveta Latest Developments
12.14 Jinyu Bio-Technology
12.14.1 Jinyu Bio-Technology Company Information
12.14.2 Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
12.14.3 Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Jinyu Bio-Technology Main Business Overview
12.14.5 Jinyu Bio-Technology Latest Developments
12.15 Phibro Animal Health
12.15.1 Phibro Animal Health Company Information
12.15.2 Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
12.15.3 Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Phibro Animal Health Main Business Overview
12.15.5 Phibro Animal Health Latest Developments
12.16 Tiankang
12.16.1 Tiankang Company Information
12.16.2 Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
12.16.3 Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Tiankang Main Business Overview
12.16.5 Tiankang Latest Developments
12.17 Zoetis
12.17.1 Zoetis Company Information
12.17.2 Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
12.17.3 Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 Zoetis Main Business Overview
12.17.5 Zoetis Latest Developments
12.18 Guangdong Yongshun Biological Pharmaceutical Co Ltd
12.18.1 Guangdong Yongshun Biological Pharmaceutical Co Ltd Company Information
12.18.2 Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
12.18.3 Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2019-2021)
12.18.4 Guangdong Yongshun Biological Pharmaceutical Co Ltd Main Business Overview
12.18.5 Guangdong Yongshun Biological Pharmaceutical Co Ltd Latest Developments
12.19 Plec Bioengineering Co., Ltd.
12.19.1 Plec Bioengineering Co., Ltd. Company Information
12.19.2 Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
12.19.3 Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2019-2021)
12.19.4 Plec Bioengineering Co., Ltd. Main Business Overview
12.19.5 Plec Bioengineering Co., Ltd. Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Live Vaccine
Table 3. Major Players of Inactivated Vaccine
Table 4. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2016-2021) & (K Units)
Table 5. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2016-2021)
Table 6. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2016-2021) & ($ million)
Table 7. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Type (2016-2021)
Table 8. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sale Price by Type (2016-2021)
Table 9. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2016-2021) & (K Units)
Table 10. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2016-2021)
Table 11. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Value by Application (2016-2021)
Table 12. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Application (2016-2021)
Table 13. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sale Price by Application (2016-2021)
Table 14. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Company (2019-2021) & (K Units)
Table 15. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Company (2019-2021)
Table 16. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Company (2019-2021)
Table 18. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Producing Area Distribution and Sales Area
Table 20. Players Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
Table 21. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2016-2021) (K Units)
Table 25. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Region (2016-2021)
Table 26. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Region (2016-2021)
Table 28. Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2016-2021) & (K Units)
Table 29. Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country (2016-2021)
Table 30. Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Country (2016-2021)
Table 32. Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2016-2021) & (K Units)
Table 33. Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2016-2021)
Table 34. Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2016-2021) & (K Units)
Table 35. Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2016-2021)
Table 36. APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2016-2021) & (K Units)
Table 37. APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Region (2016-2021)
Table 38. APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Region (2016-2021)
Table 40. APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2016-2021) & (K Units)
Table 41. APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2016-2021)
Table 42. APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2016-2021) & (K Units)
Table 43. APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2016-2021)
Table 44. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2016-2021) & (K Units)
Table 45. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country (2016-2021)
Table 46. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Country (2016-2021)
Table 48. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2016-2021) & (K Units)
Table 49. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2016-2021)
Table 50. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2016-2021) & (K Units)
Table 51. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2016-2021) & (K Units)
Table 53. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2016-2021) & (K Units)
Table 57. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2016-2021) & (K Units)
Table 59. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2016-2021)
Table 60. Key and Potential Regions of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)
Table 61. Key Application and Potential Industries of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)
Table 62. Key Challenges of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)
Table 63. Key Trends of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)
Table 64. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Distributors List
Table 65. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Customer List
Table 66. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Forecast by Region (2021-2026) & (K Units)
Table 67. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Consumption Market Forecast by Region
Table 68. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Forecast by Country (2021-2026) & (K Units)
Table 71. Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Forecast by Region (2021-2026) & (K Units)
Table 73. APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Forecast by Country (2021-2026) & (K Units)
Table 75. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Forecast by Country (2021-2026) & (K Units)
Table 77. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Forecast by Type (2021-2026) & (K Units)
Table 79. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share Forecast by Type (2021-2026)
Table 80. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 81. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share Forecast by Type (2021-2026)
Table 82. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Forecast by Application (2021-2026) & (K Units)
Table 83. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share Forecast by Application (2021-2026)
Table 84. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 85. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share Forecast by Application (2021-2026)
Table 86. CNADC Basic Information, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base, Sales Area and Its Competitors
Table 87. CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
Table 88. CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 89. CNADC Main Business
Table 90. CNADC Latest Developments
Table 91. Boehringer-Ingelheim Basic Information, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base, Sales Area and Its Competitors
Table 92. Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
Table 93. Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 94. Boehringer-Ingelheim Main Business
Table 95. Boehringer-Ingelheim Latest Developments
Table 96. MSD Animal Health Basic Information, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base, Sales Area and Its Competitors
Table 97. MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
Table 98. MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 99. MSD Animal Health Main Business
Table 100. MSD Animal Health Latest Developments
Table 101. Sinopharm Basic Information, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base, Sales Area and Its Competitors
Table 102. Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
Table 103. Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 104. Sinopharm Main Business
Table 105. Sinopharm Latest Developments
Table 106. Ceva Basic Information, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base, Sales Area and Its Competitors
Table 107. Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
Table 108. Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 109. Ceva Main Business
Table 110. Ceva Latest Developments
Table 111. Chengdu Tianbang Biological Products Co., Ltd. Basic Information, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base, Sales Area and Its Competitors
Table 112. Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
Table 113. Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 114. Chengdu Tianbang Biological Products Co., Ltd. Main Business
Table 115. Chengdu Tianbang Biological Products Co., Ltd. Latest Developments
Table 116. Tianjin Ruipu Biological Technology Co., Ltd. Basic Information, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base, Sales Area and Its Competitors
Table 117. Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
Table 118. Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 119. Tianjin Ruipu Biological Technology Co., Ltd. Main Business
Table 120. Tianjin Ruipu Biological Technology Co., Ltd. Latest Developments
Table 121. Qilu Animal Health Basic Information, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base, Sales Area and Its Competitors
Table 122. Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
Table 123. Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 124. Qilu Animal Health Main Business
Table 125. Qilu Animal Health Latest Developments
Table 126. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Basic Information, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base, Sales Area and Its Competitors
Table 127. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
Table 128. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 129. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Main Business
Table 130. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Latest Developments
Table 131. CAVAC Basic Information, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base, Sales Area and Its Competitors
Table 132. CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
Table 133. CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 134. CAVAC Main Business
Table 135. CAVAC Latest Developments
Table 136. Komipharm Basic Information, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base, Sales Area and Its Competitors
Table 137. Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
Table 138. Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 139. Komipharm Main Business
Table 140. Komipharm Latest Developments
Table 141. Agrovet Basic Information, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base, Sales Area and Its Competitors
Table 142. Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
Table 143. Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 144. Agrovet Main Business
Table 145. Agrovet Latest Developments
Table 146. Bioveta Basic Information, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base, Sales Area and Its Competitors
Table 147. Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
Table 148. Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 149. Bioveta Main Business
Table 150. Bioveta Latest Developments
Table 151. Jinyu Bio-Technology Basic Information, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base, Sales Area and Its Competitors
Table 152. Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
Table 153. Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 154. Jinyu Bio-Technology Main Business
Table 155. Jinyu Bio-Technology Latest Developments
Table 156. Phibro Animal Health Basic Information, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base, Sales Area and Its Competitors
Table 157. Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
Table 158. Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 159. Phibro Animal Health Main Business
Table 160. Phibro Animal Health Latest Developments
Table 161. Tiankang Basic Information, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base, Sales Area and Its Competitors
Table 162. Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
Table 163. Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 164. Tiankang Main Business
Table 165. Tiankang Latest Developments
Table 166. Zoetis Basic Information, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base, Sales Area and Its Competitors
Table 167. Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
Table 168. Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 169. Zoetis Main Business
Table 170. Zoetis Latest Developments
Table 171. Guangdong Yongshun Biological Pharmaceutical Co Ltd Basic Information, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base, Sales Area and Its Competitors
Table 172. Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
Table 173. Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 174. Guangdong Yongshun Biological Pharmaceutical Co Ltd Main Business
Table 175. Guangdong Yongshun Biological Pharmaceutical Co Ltd Latest Developments
Table 176. Plec Bioengineering Co., Ltd. Basic Information, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base, Sales Area and Its Competitors
Table 177. Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
Table 178. Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 179. Plec Bioengineering Co., Ltd. Main Business
Table 180. Plec Bioengineering Co., Ltd. Latest Developments
List of Figures
Figure 1. Picture of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)
Figure 2. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Live Vaccine
Figure 10. Product Picture of Inactivated Vaccine
Figure 11. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type in 2020
Figure 12. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Type (2016-2021)
Figure 13. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Consumed in Government Tender
Figure 14. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market: Government Tender (2016-2021) & (K Units)
Figure 15. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Consumed in Marketing
Figure 16. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market: Marketing (2016-2021) & (K Units)
Figure 17. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2016-2021)
Figure 18. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Application in 2020
Figure 19. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market by Company in 2020 ($ Million)
Figure 20. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Company in 2020
Figure 21. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Regions (2016-2021)
Figure 22. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Region in 2020
Figure 23. Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales 2016-2021 (K Units)
Figure 24. Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue 2016-2021 ($ Millions)
Figure 25. APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales 2016-2021 (K Units)
Figure 26. APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue 2016-2021 ($ Millions)
Figure 27. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales 2016-2021 (K Units)
Figure 28. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue 2016-2021 ($ Millions)
Figure 29. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales 2016-2021 (K Units)
Figure 30. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue 2016-2021 ($ Millions)
Figure 31. Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country in 2020
Figure 32. Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Country in 2020
Figure 33. Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type in 2020
Figure 34. Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application in 2020
Figure 35. United States Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2016-2021 ($ Millions)
Figure 36. Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2016-2021 ($ Millions)
Figure 37. Mexico Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2016-2021 ($ Millions)
Figure 38. Brazil Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2016-2021 ($ Millions)
Figure 39. APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Region in 2020
Figure 40. APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Regions in 2020
Figure 41. APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type in 2020
Figure 42. APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application in 2020
Figure 43. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2016-2021 ($ Millions)
Figure 44. Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2016-2021 ($ Millions)
Figure 45. Korea Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2016-2021 ($ Millions)
Figure 46. Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2016-2021 ($ Millions)
Figure 47. India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2016-2021 ($ Millions)
Figure 48. Australia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2016-2021 ($ Millions)
Figure 49. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country in 2020
Figure 50. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Country in 2020
Figure 51. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type in 2020
Figure 52. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application in 2020
Figure 53. Germany Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2016-2021 ($ Millions)
Figure 54. France Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2016-2021 ($ Millions)
Figure 55. UK Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2016-2021 ($ Millions)
Figure 56. Italy Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2016-2021 ($ Millions)
Figure 57. Russia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2016-2021 ($ Millions)
Figure 58. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country in 2020
Figure 59. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Country in 2020
Figure 60. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type in 2020
Figure 61. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application in 2020
Figure 62. Egypt Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2016-2021 ($ Millions)
Figure 63. South Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2016-2021 ($ Millions)
Figure 64. Israel Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2016-2021 ($ Millions)
Figure 65. Turkey Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2016-2021 ($ Millions)
Figure 66. GCC Country Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2016-2021 ($ Millions)
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
